Metabolic Status Influences Probiotic Efficacy for Depression-PRO-DEMET Randomized Clinical Trial Results.
abdominal obesity
anxiety
depression
metabolic syndrome
probiotics
stress
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
received:
08
04
2024
revised:
29
04
2024
accepted:
30
04
2024
medline:
11
5
2024
pubmed:
11
5
2024
entrez:
11
5
2024
Statut:
epublish
Résumé
Probiotics may represent a safe and easy-to-use treatment option for depression or its metabolic comorbidities. However, it is not known whether metabolic features can influence the efficacy of probiotics treatments for depression. This trial involved a parallel-group, prospective, randomized, double-blind, controlled design. In total, 116 participants with depression received a probiotic preparation containing
Identifiants
pubmed: 38732635
pii: nu16091389
doi: 10.3390/nu16091389
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT04756544']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical University of Lodz
ID : 503/1-155-02/503-11-003-20
Organisme : Medical University of Lodz
ID : 502-03/1-155-02/502-14-386-18